Skip to main content
Clinical Trials/DRKS00013729
DRKS00013729
Completed
Not Applicable

The impact of baseline left ventricular ejection fraction on 30-day and 1-year mortality after transfemoral transcatheter aortic valve implantation

niversitätsklinikum EssenWestdeutesches Herz- und Gefäßzentrum, EssenKlinik für Kardiologie und Angiologie0 sites624 target enrollmentApril 9, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
I35.0
Sponsor
niversitätsklinikum EssenWestdeutesches Herz- und Gefäßzentrum, EssenKlinik für Kardiologie und Angiologie
Enrollment
624
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 9, 2018
End Date
July 31, 2017
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsklinikum EssenWestdeutesches Herz- und Gefäßzentrum, EssenKlinik für Kardiologie und Angiologie

Eligibility Criteria

Inclusion Criteria

  • All patients with native severe aortic stenosis (AS) who underwent transfemoral transcatheter aortic valve implantation (TF\-TAVI) in West German Heart and Vascular Center, Essen, from January 2006 to July 2016\.

Exclusion Criteria

  • (1\) Severe aortic regurgitation, degenerated aortic bioprosthesis or bicuspid aortic valve as a primary indication for transfemoral transcatheter aortic valve implantation (TF\-TAVI), (2\) Baseline transthoracic echocardiography not performed in our center, (3\) TF\-TAVI abrted/not performed

Outcomes

Primary Outcomes

Not specified

Similar Trials